NCT00609492View on ClinicalTrials.gov

Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.

PHASE3CompletedINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

January 3, 2008

Primary Completion Date

November 10, 2008

Study Completion Date

March 30, 2009

Conditions
Infections, StreptococcalStreptococcus Pneumoniae Vaccines
Interventions
BIOLOGICAL

GSK Biologicals´ Pneumococcal Conjugate Vaccine (GSK1024850A)

Single dose, intramuscular injection

BIOLOGICAL

Infanrix™-IPV/Hib

Single dose, intramuscular injection

Trial Locations (7)

11527

GSK Investigational Site, Athens

28047

GSK Investigational Site, Madrid

28935

GSK Investigational Site, Móstoles/Madrid

54636

GSK Investigational Site, Thessaloniki

115 27

GSK Investigational Site, Athens

452 21

GSK Investigational Site, Ioannina

09005

GSK Investigational Site, Burgos

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY